| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | phenformin | GDSC1000 | pan-cancer | AAC | 0.044 | 0.1 |
| mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.051 | 0.1 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | -0.065 | 0.1 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.044 | 0.1 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | -0.11 | 0.2 |
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | -0.055 | 0.2 |
| mRNA | BRD-K37390332 | CTRPv2 | pan-cancer | AAC | -0.055 | 0.2 |
| mRNA | HG-5-113-01 | GDSC1000 | pan-cancer | AAC | 0.062 | 0.2 |
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | -0.07 | 0.2 |
| mRNA | Curcumin | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |